Government Information

Earl Gregg Swem Library

Setting Priorities: An Essential Step in Transforming Declassification

Categories: Govt Information,Govt Secrecy,Laws/Regulations

http://www.archives.gov/declassification/pidb/recommendations/setting-priorities.pdf

Proposes that items be declassified by the government according to priorities based on historical significance rather than age or automatic declassification of all documents.  From the Public Interest Declassification Board at the National Archives and Records Administration

 

An Analysis of the Navy’s Fiscal Year 2015 Shipbuilding Plan

Categories: Defense/Military,Govt Finance

http://www.cbo.gov/sites/default/files/cbofiles/attachments/49818-Shipbuilding.pdf

Assesses the Navy’s goal of building 264 ships over the next 30 years, provides cost estimates for such a building program, and correlates such plans with the reality of caps on defense spending.  Also provides outlook for specific ship programs.  From the Congressional Budget Office

 

Consumer Credit Reports: A Study of Medical and Non-Medical Collections

Categories: Consumer Info/Protection,Financial Crisis/Markets,Health/Medical

http://files.consumerfinance.gov/f/201412_cfpb_reports_consumer-credit-medical-and-non-medical-collections.pdf

Reports that roughly half of all items on credit reports involve debt collectors seeking to collect on medical bills owed to hospitals and other medical providers.  This paper describes characteristics of medical and nonmedical debts on consumers’ credit reports and the processes by which they appear and disappear.  From the Consumer Financial Protection Bureau

 

Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations

Categories: Great Britain,Health/Medical

http://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf

First report of a team appointed by the British Prime Minister.  Describes the potential impact on the world of antimicrobial resistance, the economic cost of drug-resistant infections, and the health implications.  From the Review on Antimicrobial Resistant